Impact of overweight and obesity on medical care costs, all-cause mortality, and the risk of cancer in Japan

Journal of Epidemiology

Volumn 16, Issue 4, 2006, Pages 139-144

  Kuriyama, Shinichi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Health expenditures; Japan; Mortality; Neoplasms; Obesity; Risk

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; OBESITY; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; BODY MASS INDEX; FEMALE; HEALTH CARE COSTS; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; OBESITY; OVERWEIGHT; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS;

EID: 33746341543     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.16.139     Document Type: Article

References (24)

1. Yoshiike N, Seino F, Tajima S, Arai Y, Kawano M, Furuhata T, et al. Twenty-year changes in the prevalence of overweight in Japanese adults: the National Nutrition Survey 1976-95. Obes Rev 2002; 3: 183-90.
2. Obesity: preventing and managing the global epidemic: Report of a WHO consultation. WHO Tech Rep Ser 2000; 894: 1-253.
3. Islam MM, Horibe H, Kobayashi F. Current trend in prevalence of diabetes mellitus in Japan, 1964-1992. J Epidemiol 1999; 9: 155-62.
4. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998; 21: 518-24.
5. Mooy JM, Grootenhuis PA, de Vries H, Valkenburg HA, Bouter LM, Kostense PJ, et al. Prevalence and determinants of glucose intolerance in a Dutch aucasian population: The Hoorn Study. Diabetes Care 1995; 18: 1270-3.
6. Kuriyama S, Tsuji I, Ohkubo T, Anzai Y, Takahashi K, Watanabe Y, et al. Medical care expenditure associated with body mass index in Japan: the Ohsaki Study. Int J Obes Relat Metab Disord 2002; 26: 1069-74.
7. Kuriyama S, Ohmori K, Miura C, Suzuki Y, Nakaya N, Fujita K, et al. Body mass index and mortality in Japan: the Miyagi Cohort Study. J Epidemiol 2004; 14 (Suppl 1): S33-S8.
8. Kuriyama S, Tsubono Y, Hozawa A, Shimazu T, Suzuki Y, Koizumi Y, et al. Obesity and risk of cancer in Japan. Int J Cancer 2005; 113: 148-57.
9. World Health Organization. International classification of diseases: manual of the international statistical classification of diseases, injuries, and causes of death. vol. 1. Geneva: World Health Organization, 1977.
10. Physical status: the use and interpretation of anthropometry: report of a WHO expert committee. WHO Tech Rep Ser 1995; 854: 1-452.
11. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998; 88: 15-9.
12. Colditz GA. Economic costs of obesity. Am J Clin Nutr 1992; 55 (2 suppl): S503-S7.
13. Wolf AM, Colditz GA. The cost of obesity: the US perspective. Pharmaco Economics 1994; 5 (suppl 1): 34-7.
14. Seidell JC, Deerenberg I. Obesity in Europe: prevalence and consequences for use of medical care. PharmacoEconomics 1994; 5 (suppl 1): 38-44.
15. Segal L, Carter R, Zimmet P. The cost of obesity: the Australian perspective. Pharmaco Economics 1994; 5(suppl 1): 45-52.
16. Lévy E, Lévy P, Pen CL, Basdevant A. The economic cost of obesity: the French situation. Int J Obes Relat Metab Disord. 1995; 19: 788-92.
17. Swinburn B, Ashton T, Gillespie J, Cox B, Menon A, Simmons D, et al. Health care costs of obesity in New Zealand. Int J Obes Relat Metab Disord 1997; 21: 891-6.
18. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res 1998; 6: 97-106.
19. Quesenberry CPJr, Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med 1998; 158: 466-72.
20. Birmingham CL, Muller JL, Palepu A, Spinelli JJ, Anis AH. The cost of obesity in Canada. CMAJ 1999; 160: 483-8.
21. Detournay B, Fagnani F, Phillippo M, Pribil C, Charles MA, Sermet C, et al. Obesity morbidity and health care costs in France: an analysis of the 1991-1992 Medical Care Household Survey. Int J Obes Relat Metab Disord 2000; 24: 151-5.
22. Song YM, Sung J. Body mass index and mortality: a twelve-year prospective study in Korea. Epidemiology 2001; 12: 173-9.
23. Polednak AP. Trends in incidence rates for obesity-associated cancers in the US. Cancer Detect Prev 2003; 27; 415-21.
24. Bergström A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001; 91: 421-30. Erratum, Int J Cancer 2001; 92: 927.